| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| John A Lawson, Ingrid E Scheffe. Therapeutic use of medicinal cannabis in difficult to manage epilepsy. British journal of clinical pharmacology. vol 84. issue 11. 2019-11-14. PMID:30088286. |
therapeutic use of medicinal cannabis in difficult to manage epilepsy. |
2019-11-14 |
2023-08-13 |
Not clear |
| Nicola Pietrafusa, Alessandro Ferretti, Marina Trivisano, Luca de Palma, Costanza Calabrese, Giusy Carfì Pavia, Ilaria Tondo, Simona Cappelletti, Federico Vigevano, Nicola Specchi. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy. Paediatric drugs. vol 21. issue 4. 2019-10-30. PMID:31179531. |
purified cannabidiol for treatment of refractory epilepsies in pediatric patients with developmental and epileptic encephalopathy. |
2019-10-30 |
2023-08-13 |
Not clear |
| Renata K Carvalho, Monaliza L Santos, Maingredy R Souza, Thiago L Rocha, Francisco S Guimarães, Janete A Anselmo-Franci, Renata Mazaro-Cost. Chronic exposure to cannabidiol induces reproductive toxicity in male Swiss mice. Journal of applied toxicology : JAT. vol 38. issue 9. 2019-10-25. PMID:29766538. |
children and adults with frequent and severe episodes of epilepsy that do not respond to standard treatments (such as carbamazepine, phenytoin and valproate) have long been prescribed cannabidiol (cbd) as an anticonvulsant drug. |
2019-10-25 |
2023-08-13 |
mouse |
| A Suraev, N Lintzeris, J Stuart, R C Kevin, R Blackburn, E Richards, J C Arnold, C Ireland, L Todd, D J Allsop, I S McGrego. Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community. Scientific reports. vol 8. issue 1. 2019-10-09. PMID:29977078. |
composition and use of cannabis extracts for childhood epilepsy in the australian community. |
2019-10-09 |
2023-08-13 |
Not clear |
| A Suraev, N Lintzeris, J Stuart, R C Kevin, R Blackburn, E Richards, J C Arnold, C Ireland, L Todd, D J Allsop, I S McGrego. Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community. Scientific reports. vol 8. issue 1. 2019-10-09. PMID:29977078. |
recent surveys suggest that many parents are using illicit cannabis extracts in the hope of managing seizures in their children with epilepsy. |
2019-10-09 |
2023-08-13 |
Not clear |
| A Suraev, N Lintzeris, J Stuart, R C Kevin, R Blackburn, E Richards, J C Arnold, C Ireland, L Todd, D J Allsop, I S McGrego. Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community. Scientific reports. vol 8. issue 1. 2019-10-09. PMID:29977078. |
in the current australian study we conducted semi-structured interviews with families of children with diverse forms of epilepsy to explore their attitudes towards and experiences with using cannabis extracts. |
2019-10-09 |
2023-08-13 |
Not clear |
| A Suraev, N Lintzeris, J Stuart, R C Kevin, R Blackburn, E Richards, J C Arnold, C Ireland, L Todd, D J Allsop, I S McGrego. Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community. Scientific reports. vol 8. issue 1. 2019-10-09. PMID:29977078. |
results showed that children given cannabis extracts tended to have more severe epilepsy historically and had trialled more anticonvulsants than those who had never received cannabis extracts. |
2019-10-09 |
2023-08-13 |
Not clear |
| Emily Stockings, Dino Zagic, Gabrielle Campbell, Megan Weier, Wayne D Hall, Suzanne Nielsen, Geoffrey K Herkes, Michael Farrell, Louisa Degenhard. Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence. Journal of neurology, neurosurgery, and psychiatry. vol 89. issue 7. 2019-10-04. PMID:29511052. |
evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence. |
2019-10-04 |
2023-08-13 |
human |
| Paul E Sanmartin, Kamil Detynieck. Cannabidiol for Epilepsy: New Hope on the Horizon? Clinical therapeutics. vol 40. issue 9. 2019-09-30. PMID:30150078. |
cannabidiol for epilepsy: new hope on the horizon? |
2019-09-30 |
2023-08-13 |
Not clear |
| Paul E Sanmartin, Kamil Detynieck. Cannabidiol for Epilepsy: New Hope on the Horizon? Clinical therapeutics. vol 40. issue 9. 2019-09-30. PMID:30150078. |
we begin by exploring the early and somewhat anecdotal evidence that was recently replaced by high-quality data from randomized controlled studies, which subsequently led to the us food and drug administration approval of a purified cannabidiol extract for the treatment of 2 highly refractory pediatric epilepsy syndromes (dravet and lennox-gastaut). |
2019-09-30 |
2023-08-13 |
Not clear |
| Tyler E Gaston, Jerzy P Szaflarsk. Cannabis for the Treatment of Epilepsy: an Update. Current neurology and neuroscience reports. vol 18. issue 11. 2019-09-17. PMID:30194563. |
cannabis for the treatment of epilepsy: an update. |
2019-09-17 |
2023-08-13 |
Not clear |
| Tyler E Gaston, Jerzy P Szaflarsk. Cannabis for the Treatment of Epilepsy: an Update. Current neurology and neuroscience reports. vol 18. issue 11. 2019-09-17. PMID:30194563. |
for millennia, there has been interest in the use of cannabis for the treatment of epilepsy. |
2019-09-17 |
2023-08-13 |
Not clear |
| Tyler E Gaston, Jerzy P Szaflarsk. Cannabis for the Treatment of Epilepsy: an Update. Current neurology and neuroscience reports. vol 18. issue 11. 2019-09-17. PMID:30194563. |
in this review, we present an update on the research investigating the use of cannabidiol (cbd), a non-psychoactive component of cannabis, in the treatment of epilepsy. |
2019-09-17 |
2023-08-13 |
Not clear |
| Stijntje Dijk, Pat Lo. NICE rejects cannabidiol for two types of treatment resistant epilepsy in children. BMJ (Clinical research ed.). vol 366. 2019-08-27. PMID:31444166. |
nice rejects cannabidiol for two types of treatment resistant epilepsy in children. |
2019-08-27 |
2023-08-13 |
Not clear |
| Serena Silvestro, Santa Mammana, Eugenio Cavalli, Placido Bramanti, Emanuela Mazzo. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials. Molecules (Basel, Switzerland). vol 24. issue 8. 2019-08-14. PMID:31013866. |
use of cannabidiol in the treatment of epilepsy: efficacy and security in clinical trials. |
2019-08-14 |
2023-08-13 |
Not clear |
| Archie A Khan, Tawfeeq Shekh-Ahmad, Ayatakin Khalil, Matthew C Walker, Afia B Al. Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model. British journal of pharmacology. vol 175. issue 11. 2019-08-06. PMID:29574880. |
a non-psychoactive phytocannabinoid, cannabidiol (cbd), shows promising results as an effective potential antiepileptic drug in some forms of refractory epilepsy. |
2019-08-06 |
2023-08-13 |
Not clear |
| Simona Lattanzi, Francesco Brigo, Eugen Trinka, Gaetano Zaccara, Claudia Cagnetti, Cinzia Del Giovane, Mauro Silvestrin. Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis. Drugs. vol 78. issue 17. 2019-07-31. PMID:30390221. |
efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis. |
2019-07-31 |
2023-08-13 |
Not clear |
| Charlotte Ridle. Epilepsy: Cannabidiol reduces seizure frequency in Dravet syndrome. Nature reviews. Neurology. vol 13. issue 7. 2019-07-24. PMID:28621765. |
epilepsy: cannabidiol reduces seizure frequency in dravet syndrome. |
2019-07-24 |
2023-08-13 |
Not clear |
| Tristan Dale, Jenny Downs, Heather Olson, Ann Marie Bergin, Stephanie Smith, Helen Leonar. Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder. Epilepsy research. vol 151. 2019-07-12. PMID:30771550. |
cannabis for refractory epilepsy in children: a review focusing on cdkl5 deficiency disorder. |
2019-07-12 |
2023-08-13 |
Not clear |
| Tristan Dale, Jenny Downs, Heather Olson, Ann Marie Bergin, Stephanie Smith, Helen Leonar. Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder. Epilepsy research. vol 151. 2019-07-12. PMID:30771550. |
the evidence supports the use of cannabinoids, especially cannabidiol, in similar forms of refractory epilepsy including dravet and lennox-gastaut syndromes. |
2019-07-12 |
2023-08-13 |
Not clear |